yh4808
Small moleculeexperimental
Clinical trial activity
9 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
8
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2009 (NCT01007019)
Timeline
Indications
Mechanism of action
ATP4A inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- yh4808
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02176668 | Phase 1 | Jun 1, 2014 | Yonsei University, Yuhan Pharmaceutical Company |
| NCT02072447 | Early Phase 1 (Phase 1) | Mar 1, 2014 | Seoul National University |
| NCT01876615 | Phase 1 | Jul 1, 2013 | Chungnam National University, Yuhan Pharmaceutical Company |
| NCT01921647 | Phase 1 | Jul 1, 2013 | Yonsei University, Yuhan Pharmaceutical Company |
| NCT01825707 | Phase 1 | Jan 1, 2013 | Covance, Yuhan Pharmaceutical Company |
| NCT01538849 | Phase 2 | Dec 1, 2012 | Catholic University of Korea, Yuhan Pharmaceutical Company |
| NCT01761513 | Phase 1 | Nov 1, 2012 | Yonsei University, Yuhan Pharmaceutical Company |
| NCT01520012 | Phase 1 | Feb 1, 2012 | Seoul National University, Yuhan Pharmaceutical Company |
| NCT01007019 | Phase 1 | Nov 1, 2009 | Seoul National University, Yuhan Pharmaceutical Company |
Showing 9 of 9 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Yuhan Pharmaceutical Company | For profit | 8 | 8 | 2 | 2009 |
| Seoul National University | Academic/Hospital | 3 | 1 | 1 | 2009 |
| Yonsei University | Academic/Hospital | 3 | 0 | 1 | 2012 |
| Catholic University of Korea | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Chungnam National University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Covance | For profit | 1 | 0 | 1 | 2013 |
6 organizations
Page 1 / 1